Literature DB >> 25284955

The Autodigestion Hypothesis in Shock and Multi-Organ Failure: Degrading Protease Activity.

Geert W Schmid-Schönbein1, Alex Penn1, Erik Kistler1.   

Abstract

Shock and multi-organ failure have one of the highest levels of inflammatory markers, morbidities and mortality. The underlying mechanisms are currently unknown and no effective intervention exists. We present evidence for a previously untested mechanism due to autodigestion by the digestive enzymes synthesized in the pancreas and transported in the lumen of the intestine as normal part of food digestion. We summarize experimental evidence in support of the autodigestion hypothesis and a new approach for possible intervention against multi-organ failure that is currently entering clinical trials.

Entities:  

Keywords:  Intestine; chymotrypsin; digestive pancreas; elastase; hemorrhagic shock; inflammation; intestinal mucosa; sepsis; trypsin

Year:  2011        PMID: 25284955      PMCID: PMC4180238     

Source DB:  PubMed          Journal:  Bol Soc Port Hemorreol Microcirc        ISSN: 0872-4938


  42 in total

1.  Inhibition of intraluminal pancreatic enzymes with nafamostat mesilate improves clinical outcomes after hemorrhagic shock in swine.

Authors:  Hubert D Kim; Darren J Malinoski; Boris Borazjani; Madhukar S Patel; Joseph Chen; Johnathan Slone; Xuan-Mai T Nguyen; Earl Steward; Geert W Schmid-Schonbein; David B Hoyt
Journal:  J Trauma       Date:  2010-05

2.  Mechanisms for blockade of in vivo activator production in the ischemic intestine and multi-organ failure.

Authors:  H Mitsuoka; G W Schmid-Schönbein
Journal:  Shock       Date:  2000-11       Impact factor: 3.454

Review 3.  Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy.

Authors:  John M Harlan; Robert K Winn
Journal:  Crit Care Med       Date:  2002-05       Impact factor: 7.598

Review 4.  Markers of inflammation and their clinical significance.

Authors:  Christie M Ballantyne; Vijay Nambi
Journal:  Atheroscler Suppl       Date:  2005-05       Impact factor: 3.235

Review 5.  Novel clinical markers of vascular wall inflammation.

Authors:  G J Blake; P M Ridker
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

Review 6.  Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies.

Authors:  Andre C Kalil; Junfeng Sun
Journal:  Intensive Care Med       Date:  2011-01-18       Impact factor: 17.440

Review 7.  Resolution, the grail for healthy ocular inflammation.

Authors:  Karsten Gronert
Journal:  Exp Eye Res       Date:  2010-07-14       Impact factor: 3.467

8.  Inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock.

Authors:  Jay J Doucet; David B Hoyt; Raul Coimbra; Geert W Schmid-Schönbein; Wolfgang G Junger; Wolf Paul L; William H Loomis; Ton E Hugli
Journal:  J Trauma       Date:  2004-03

9.  Pancreatic protease inhibition during shock attenuates cell activation and peripheral inflammation.

Authors:  Florian Fitzal; Frank A DeLano; Corey Young; Henrique S Rosario; Geert W Schmid-Schönbein
Journal:  J Vasc Res       Date:  2002 Jul-Aug       Impact factor: 1.934

Review 10.  Cytokine modulation in sepsis and septic shock.

Authors:  Sergio Zanotti; Aseem Kumar; Anand Kumar
Journal:  Expert Opin Investig Drugs       Date:  2002-08       Impact factor: 6.206

View more
  1 in total

Review 1.  Challenge to the Intestinal Mucosa During Sepsis.

Authors:  Felix Haussner; Shinjini Chakraborty; Rebecca Halbgebauer; Markus Huber-Lang
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.